Practical Reviews

Original, New Treatment for Parkinson Disease

Background: The mainstay of treatment for Parkinson disease (PD) is oral levodopa, which leads to increased levels of dopamine in the brain. This treatment has severe adverse long-term effects, such as dyskinesias treated with monoamine oxidase inhibitors and anticholinergic agents. Stem cells isolated from a patient’s own bone marrow have been shown to be able to differentiate into neurons and other tissues. Transvenous infusion does not allow directed therapy. Objective: Th more...
To view this content, you must be a logged in subscriber to
Please Login to view this content.